Evidence map›Paper›PMID 34437902›Full record

ArticleThe Journal of biological chemistry2021

N-acetylmannosamine-6-phosphate 2-epimerase uses a novel substrate-assisted mechanism to catalyze amino sugar epimerization.

Michael J Currie, Lavanyaa Manjunath, Christopher R Horne, Phillip M Rendle, Ramaswamy Subramanian, Rosmarie Friemann, Antony J Fairbanks, Andrew C Muscroft-Taylor, Rachel A North, Renwick C J Dobson

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Michael J CurrieBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
Lavanyaa ManjunathInstitute of Stem Cell Science and Regenerative Medicine, NCBS, Bangalore, Karnataka, India.
Christopher R HorneBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
Phillip M RendleFerrier Research Institute, Victoria University of Wellington, Lower Hutt, New Zealand.
Ramaswamy SubramanianInstitute of Stem Cell Science and Regenerative Medicine, NCBS, Bangalore, Karnataka, India.
Rosmarie FriemannFujirebio Diagnostics, Gothenburg, Sweden; Centre for Antibiotic Resistance Research (CARe), University of Gothenburg, Gothenburg, Sweden.
Antony J FairbanksBiomolecular Interaction Centre and School of Physical and Chemical Sciences, University of Canterbury, Christchurch, New Zealand.
Andrew C Muscroft-TaylorBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
Rachel A NorthBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand; Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden. Electronic address: rachel.north@dbb.su.se.
Renwick C J DobsonBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: renwick.dobson@canterbury.ac.nz.
University of Canterbury · NZInstitute for Stem Cell Biology and Regenerative Medicine · INStockholm University · SEThe University of Melbourne · AUUniversity of Gothenburg · SEVictoria University of Wellington · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are five known general catalytic mechanisms used by enzymes to catalyze carbohydrate epimerization. The amino sugar epimerase N-acetylmannosamine-6-phosphate 2-epimerase (NanE) has been proposed to use a deprotonation-reprotonation mechanism, with an essential catalytic lysine required for both steps. However, the structural determinants of this mechanism are not clearly established. We characterized NanE from Staphylococcus aureus using a new coupled assay to monitor NanE catalysis in real time and found that it has kinetic constants comparable with other species. The crystal structure of NanE from Staphylococcus aureus, which comprises a triosephosphate isomerase barrel fold with an unusual dimeric architecture, was solved with both natural and modified substrates. Using these substrate-bound structures, we identified the following active-site residues lining the cleft at the C-terminal end of the β-strands: Gln11, Arg40, Lys63, Asp124, Glu180, and Arg208, which were individually substituted and assessed in relation to the mechanism. From this, we re-evaluated the central role of Glu180 in this mechanism alongside the catalytic lysine. We observed that the substrate is bound in a conformation that ideally positions the C5 hydroxyl group to be activated by Glu180 and donate a proton to the C2 carbon. Taken together, we propose that NanE uses a novel substrate-assisted proton displacement mechanism to invert the C2 stereocenter of N-acetylmannosamine-6-phosphate. Our data and mechanistic interpretation may be useful in the development of inhibitors of this enzyme or in enzyme engineering to produce biocatalysts capable of changing the stereochemistry of molecules that are not amenable to synthetic methods.

Indexed as

Amino Acid SubstitutionBacterial ProteinsCarbohydrate EpimerasesCatalysisHexosaminesMutation, MissenseProtein Conformation, beta-StrandProtein DomainsStaphylococcus aureusSugar PhosphatesBacterial ProteinsCarbohydrate EpimerasesHexosaminesN-acetylmannosamine 6-phosphateN-acetylmannosamine-6-phosphate epimeraseSugar Phosphatescrystal structureenergy metabolismenzyme mechanismepimeraseGlcNAc-6PManNAc-6Pmethicillin-resistant Staphylococcus aureussialic acid

Identifiers

PMID34437902
PMCPMC8482478
OpenAlexW3194498271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.